8 medications · 2 drug classes

GLP-1 Medications

Compare FDA-approved and compounded GLP-1 medications. Pricing, side effects, savings cards, and provider availability.

GLP-1 Agonists

Compounded Semaglutide

semaglutide (compounded)

Compounded semaglutide is a non-FDA-approved version of the GLP-1 medication used for weight loss. Subject to FDA enforcement following March 2026 warning letters.

$99/mo

FDA approved

Ozempic

semaglutide

Ozempic is a once-weekly GLP-1 injection FDA-approved for Type 2 diabetes. It is widely prescribed off-label for weight loss.

$968/mo

FDA approved

Rybelsus

semaglutide

Rybelsus is the only oral GLP-1 medication — daily tablet form of semaglutide FDA-approved for Type 2 diabetes.

$850/mo

FDA approved

Saxenda

liraglutide

Saxenda is a once-daily liraglutide injection FDA-approved for chronic weight management in adults and adolescents 12+ with obesity.

$1100/mo

FDA approved

Wegovy

semaglutide

Wegovy is the FDA-approved version of semaglutide specifically for chronic weight management in adults with obesity.

$1349/mo

GIP/GLP-1 Co-agonists

Compounded

Compounded Tirzepatide

tirzepatide (compounded)

Compounded tirzepatide is a non-FDA-approved version of the GIP/GLP-1 medication. Subject to ongoing FDA enforcement scrutiny.

$149/mo

FDA approved

Mounjaro

tirzepatide

Mounjaro is a dual GIP/GLP-1 co-agonist FDA-approved for Type 2 diabetes, often more effective than semaglutide for weight loss in clinical trials.

$1023/mo

FDA approved

Zepbound

tirzepatide

Zepbound is the FDA-approved version of tirzepatide for chronic weight management in adults with obesity.

$349/mo